Buy now for a near-term swing setup: price is holding above key support (S1 ~16.38) with bullish moving-average structure, suggesting dips are being bought.
Options positioning is notably bullish (call-heavy put/call ratios) and implies traders are leaning upside into the next few weeks.
Wall Street tone has improved recently (multiple Buys/upgrades and higher targets), supporting a “buy-it-now” stance for an impatient investor.
Main near-term risk is momentum softening (bearish MACD) and earnings on 2026-02-18 (after hours), which can cause sharp moves.
Overall: growth is returning on revenue, but earnings/margins need to re-accelerate to fully support a sustained re-rating.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend: net improving tone with multiple bullish actions since late Nov (Argus upgrade to Buy; Citi reiterating Buy and raising PT; Maxim initiating Buy).
Not universally bullish: Mizuho remains Neutral (raised PT to $13) and BofA remains Underperform (raised PT to $8), highlighting ongoing skepticism.
Price targets span widely ($8 to $20), implying disagreement and higher uncertainty.
Wall Street pros: turnaround underway, regulatory overhang viewed as largely resolved by some, distributor engagement improving.
Wall Street cons: concerns about fundamentals durability, competition/macro uncertainty, and limited prospects for broad valuation recovery per more cautious shops.
Influential/political trading: No recent congress trading data available; hedge funds/insiders reported as Neutral with no significant recent trend.
Wall Street analysts forecast HLF stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for HLF is 14.6 USD with a low forecast of 8 USD and a high forecast of 20 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
Wall Street analysts forecast HLF stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for HLF is 14.6 USD with a low forecast of 8 USD and a high forecast of 20 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
1 Hold
1 Sell
Moderate Buy
Current: 16.690
Low
8
Averages
14.6
High
20
Current: 16.690
Low
8
Averages
14.6
High
20
Mizuho
Neutral
maintain
$11 -> $13
AI Analysis
2026-01-08
Reason
Mizuho
Price Target
$11 -> $13
AI Analysis
2026-01-08
maintain
Neutral
Reason
Mizuho raised the firm's price target on Herbalife to $13 from $11 and keeps a Neutral rating on the shares. The firm adjusted targets in the food producers space as part of its 2026 outlook. Healthy living growth should outperform in 2026, but concerns for competition have compressed valuations, the analyst tells investors in a research note. Mizuho believes weak fundamentals and elevated macro uncertainty "suggest limited prospects for a broad valuation recovery."
Maxim
Anthony Vendetti
Buy
initiated
$20
2026-01-06
Reason
Maxim
Anthony Vendetti
Price Target
$20
2026-01-06
initiated
Buy
Reason
Maxim analyst Anthony Vendetti initiated coverage of Herbalife with a Buy rating and $20 price target. A turnaround is underway, enabling Herbalife to solidify its status as a leading provider of health and wellness products, the analyst tells investors in a research note. Maxim believes the U.S. regulatory concerns are resolved, and the resulting changes, including closer alignment of distributor compensation with sales to end users, have established a more sustainable business model.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for HLF
